References
- Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med 1995;155(18): 1949–56
- Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA 1997; 277(4): 301–6
- Bates DW, Cullen DJ, Laird N, et al, for the ADE Prevention Study Group. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA 1995; 274(1): 29–34
- Leape LL, Bates DW, Cullen DJ, et al, for the ADE Prevention Study Group. Systems analysis of adverse drug events. JAMA 1995; 274(1): 35–43
- Bates DW, Spell N, Cullen DJ, et al, for the Adverse Drug Events Prevention Study Group. The costs of adverse drug events in hospitalized patients. JAMA 1997; 277(4): 307–11
- Asch DA, Parker RM. The Libby Zion case: one step forward or two steps backward? N Engl J Med 1988; 318(12): 771–5
- Meperidine and phenelzine manufacturer's package insert information. In: Physicians' desk reference. 51st ed. Montvale, NJ: Medical Economics, 1997
- Headden S, Lenzy T, Lostyu P, et al. Danger at the drugstore. US News and World Report 1996 Aug 26
- Slaughter RL, Edwards DJ. Recent advances: the cytochrome P450 enzymes. Ann Pharmacother 1995; 29(6): 619–24
- Krishna DR, Klotz U. Extrahepatic metabolism of drugs in humans. Clin Pharmacokinet 1994; 26(2): 144–60
- Nebert DW, Adesnik M, Coon MJ, et al. The P450 gene superfamily: recommended nomenclature. DNA 1987; 6(1): 1–11
- Slaughter RL. Clinical relevance of cytochrome P450 enzymes. Hosp Pharm Times 1996 Jul; 6–15HPT
- Gillum JG, Israel DS, Polk RE. Pharmacokinetic drug interactions with antimicrobial agents. Clin Pharmacokinet 1993; 25(6): 450–82
- Cupp MJ, Tracy TS. Role of the cytochrome P4503A subfamily in drug interactions. US Pharmacist 1997 Jan; HS9–21
- Dossing M, Pilsgaard H, Rasmussen B, et al. Time course of phenobarbital and Cimetidine mediated changes in hepatic drug metabolism. Eur J Clin Pharmacol 1983; 25(2): 215–22
- Parkinson A. Biotransformation of Xenobiotics. In: Klaassen CD, Amdur MO, Doull J, eds. Casarett and Doull's toxicology: the basic science of poisons. 5th ed. New York: McGraw-Hill, 1996, chap 6
- Quinn DI, Day RO. Drug interactions of clinical importance: an updated guide. Drug Saf 1995; 12(6): 393–452
- Riesenman C. Antidepressant drug interactions and the cytochrome P450 system: a critical appraisal. Pharmacotherapy 1995; 15(6 Pt 2): 84–99S
- Ereshefsky L. Drug interactions of antidepressants. Psychiatric Annals 1996; 26(6): 342–50
- GI stimulants: cisapride. In: Olin BR, ed. Drug facts and comparisons. St Louis: Drug Facts and Comparisons, 1996: 308b–e